Magnesium Sulfate Svp Pharma

Magnesium sulfate, the active ingredient in Magnesium Sulfate Svp Pharma, is a magnesium supplement presented as a solution for injection for intramuscular and intravenous use. It treats magnesium deficiency, prevents and treats eclampsia and severe preeclampsia, and is used in the management of torsades de pointes and tocolysis.

GNH USA supplies Magnesium Sulfate Svp Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium sulfate is employed in obstetric, cardiac and electrolyte‑balance therapeutic pathways.

Eclampsia and severe preeclampsia: prevention of maternal seizures and stabilization of blood pressure. Magnesium deficiency: restoration of normal serum magnesium levels. Torsades de pointes: reduction of ventricular arrhythmia recurrence. Tocolysis: inhibition of uterine contractions to delay preterm labor.

Magnesium sulfate may cause a range of adverse reactions.

Common Side Effects: - Flushing or feeling of warmth. - Sweating and mild skin erythema. - Nausea, vomiting or abdominal discomfort. - Headache or dizziness. - Transient muscle weakness or loss of deep tendon reflexes.

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse. - Respiratory depression or apnea. - Cardiac arrhythmias, including heart block. - Hypermagnesemia with neuromuscular paralysis. - Renal failure exacerbation. - Anaphylactoid reactions at the injection site.

Magnesium sulfate requires careful clinical monitoring.

Monitor serum magnesium levels: adjust infusion to maintain therapeutic range. Assess renal function before and during therapy: impaired clearance increases toxicity risk. Use cautiously in patients with myasthenia gravis or neuromuscular disorders. Avoid rapid intravenous bolus: administer slowly to reduce hypotension. Contraindicated in advanced heart block without a pacemaker. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several drug classes.

Major Interactions (Avoid): - Concurrent use of other magnesium‑containing products: risk of hypermagnesemia. - Neuromuscular blocking agents: potentiation of blockade leading to respiratory failure. - Vasodilators (e.g., nitroglycerin): additive hypotensive effect.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: enhanced nephrotoxicity. - Loop diuretics: increased magnesium loss, may require dose adjustment. - ACE inhibitors or ARBs: may raise serum magnesium levels. - Calcium channel blockers: additive cardiovascular effects.